Travel Guide · 5 min read
How much does stem cell therapy cost in Mexico vs the US?
Reference prices by condition, what the price includes and what makes it go up or down, so you can compare the whole trip.
Short answer
At Stemlife, stem cell treatment starts at USD 5,000, with reference ranges by condition from USD 5,000 to 15,000. Comparable private programs in the US are usually around USD 15,000 or more and are rarely covered by insurance. Your exact price is confirmed in a written plan after a free medical review of your imaging.
In 30 seconds
- Reference prices start at USD 5,000; the range depends on the condition and the protocol.
- The plan includes the medical assessment, the application at the hospital, the cells and follow-up.
- You get one written plan with the total cost, including hotel and transfers, before you pay or travel.
How much does it cost by condition?
These are the reference prices we publish, in US dollars. The final figure depends on how advanced the condition is and on the protocol the physician recommends after reviewing your imaging.
Systemic conditions, such as autoimmune or metabolic diseases, are quoted after a medical assessment, because the protocol depends on each case and on the treatment you already receive.
What does the price include?
- A free medical assessment of your imaging before you pay anything.
- One written plan with dates, total cost, hotel and transfers.
- The application, in a single day, at Hospital Puerta de Hierro Andares.
- Mesenchymal stem cells from Wharton’s jelly, with laboratory quality controls.
- A medical check before you fly home.
- Follow-up at 30, 90 and 180 days, with your local doctor in copy.
Why is it less expensive than in the US?
Hospital and operating costs in Guadalajara are lower than in most US cities, and orthopedic stem cell treatments are not FDA-approved uses, so US programs are private, out-of-pocket and usually priced higher. A lower price does not change the medical process: the same assessment, hospital standards and follow-up apply.
| Item | Stemlife, Guadalajara | Typical US private program |
|---|---|---|
| Reference price | From USD 5,000 | Around USD 15,000 or more |
| Hospital setting | Hospital Puerta de Hierro Andares | Varies by clinic |
| Insurance | Itemised invoice for possible reimbursement | Usually not covered |
| Written total before paying | Yes | Varies |
What changes the price?
Three things move the price within a range: the condition being treated, how advanced it is on your imaging, and the protocol your physician designs. You will know the exact number before you book anything.
Is this for you?
- You want to know your exact price before you decide.
- You have recent imaging of the area that hurts.
- You prefer one plan with the total cost of the trip, not separate bills.
Frequently asked questions
Is the price on the website my final price?
No. They are reference prices in USD. Your final price is confirmed in a written plan after a free medical review of your imaging.
Do I pay for the assessment?
No. The first call and the medical review of your imaging are free. If you are not a candidate, it ends there.
Are flights included?
Flights are not included, but your written plan lists the total cost of the stay, with hotel and transfers, so you can compare the whole trip.
Does insurance cover it?
Usually not. We provide an itemised invoice and a medical report you can submit to your insurer.
Stemlife Clinic at a glance
- Location
- Guadalajara, Mexico · Hospital Puerta de Hierro Andares
- Cells
- Mesenchymal stem cells from Wharton’s jelly (umbilical cord)
- Treatment
- One application in a single day; plan 2–3 days in Guadalajara
- Price
- From USD 5,000, confirmed after a free medical assessment
Medically reviewed by Dr. Guillermo Quezada Navarro · November 2026
Sources
- FDA · Consumer alert on regenerative medicine products, including stem cells and exosomes
- Efficacy and safety of mesenchymal stem cells in knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Stem Cell Res Ther. 2025.
- Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: an updated systematic review and meta-analysis. EClinicalMedicine. 2020.
General educational information. Individual results vary and are not guaranteed.
